Fig. 5
Localization of gamma-aminobutyric acid-B (GABAB) type 1 (a–h) and 2 (i–p) by immunohistochemistry 4 weeks after spinal cord injury (SCI), spinal cord transverse section (× 10). Control (a); SCI (b); vehicle (c); laser (d); hADSCs (cells labeled by DiI, red) (e); hADSCs (anti-anti-GABAB-1 conjugated whit FITC, green) (f); laser+hADSCs (red) (g); laser+hADSCs (green) (h), Control (i); SCI (j); vehicle (k); laser (l); hADSCs (red) (m); hADSCs (anti-anti-GABAB-2 conjugated whit FITC, green) (n); laser+hADSCs (red) (o); laser+hADSCs (green) (p)